Muhammed Murtaza

Muhammed Murtaza is a scientific advisor at PetDx and an associate professor at the University of Wisconsin-Madison. Muhammed has also worked as an assistant professor of medicine at Mayo Clinic and as a visiting researcher at Wellcome Trust Sanger Institute.

Murtaza has a PhD from Cancer Research UK, where they worked with Dr Nitzan Rosenfeld on amplicon sequencing method for ctDNA analysis (Science Translational Medicine 2012), ctDNA monitoring in breast cancer (NEJM 2013), and whole-exome sequencing of ctDNA to monitor cancer evolution and acquired resistance (Nature 2013).

Murtaza also worked with Prof Panos Deloukas at the Wellcome Trust Sanger Institute on a genome wide association study (GWAS) of cardiovascular diseases in South Asians (published in Nature Genetics) and a candidate genes study of human height (published in American Journal of Human Genetics).

Muhammed Murtaza has a Ph.D. from the University of Cambridge in Oncology and Cancer Genomics, which they obtained in 2014. Muhammed also has an MBBS from Aga Khan University, which they obtained in 2010, and a degree in Cell and Molecular Biology from Winona State University, which they obtained in 2004.